The latest report Insomnia Pipeline Highlights - 2014 Update, provides
most up-to-date information on key pipeline molecules in the global
Insomnia market. It covers emerging therapies for Insomnia in active
clinical development stages including early and late stage clinical
trials. The pipeline data presented in this report helps executives for
tracking competition, identifying partners,evaluating opportunities,
formulating business development strategies, and executing in-licensing
and out-licensing deals.

- The report provides Insomnia pipeline molecules by their dominant
mechanism of action. This helps executives categorize molecules based on
their drug class and also assess the strengths and weaknesses of
compounds.